Tech Company Financing Transactions
Valencell Funding Round
Best Buy Capital, TDF Ventures and True Ventures participated in a $7 million Series C venture round for Valencell. This venture round was announced on 6/16/2014.
Transaction Overview
Company Name
Announced On
6/16/2014
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series C
Investors
Proceeds Purpose
Valencell will use the investment to support the increasing market demand, further technological development, sales and marketing of its PerformTek - powered biometric sensors, which measure real-time heart rate and activity continuously on anyone, doing anything.
Company Information
Company Status
Private & Independent
Industry
Mobile
Mailing Address
4601 Six Forks Rd. 103
Raleigh, NC 27609
USA
Raleigh, NC 27609
USA
Phone
Website
Email Address
Overview
Valencell's proprietary Healthsnet techology turns mobile devices into health and fitness devices, addressing the growing demand for seamless monitoring of physical performance, fitness, and health status.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kent Novak
President
Steven LeBoeuf
VP - Bus. Development
Mark Felice
VP - Finance
Todd Ackman
VP - Marketing
Ryan Kraudel
VP - R & D
Michael Aumer
Browse more venture capital transactions:
Prev: 6/16/2014: Brain Parade venture capital transaction
Next: 6/16/2014: Romark Laboratories venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs